Risser Eric Blasius — SEC Form 4 Insider Trading Activity
Summary
Updated Jul 16, 2026
Risser Eric Blasius is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days.
Profile
Eric Blasius Risser is the President and CEO of Macrogenics Inc, a biotechnology company specializing in antibody-based therapeutics for cancer treatment. He has held the role of Director and has been involved in the company's strategic direction and product development.
Role
President and CEO, Director
Notability
30/100
Board memberships
Macrogenics Inc
Awards & honors
Led Macrogenics as President and CEO
Oversaw development of MARGENZA
Directed clinical development of proprietary product candidates
Eric Blasius Risser is the President and CEO of Macrogenics Inc, a biotechnology company specializing in antibody-based therapeutics for cancer treatment. He has held the role of Director and has been involved in the company's strategic direction and product development.…
Where can I see all of Risser Eric Blasius's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
